X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10672) 10672
Publication (870) 870
Book Review (230) 230
Book Chapter (23) 23
Conference Proceeding (21) 21
Book / eBook (1) 1
Magazine Article (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10251) 10251
animals (9016) 9016
tyrosine 3-monooxygenase - metabolism (6189) 6189
neurosciences (5321) 5321
male (5280) 5280
rats (5101) 5101
female (2650) 2650
immunohistochemistry (2560) 2560
mice (2466) 2466
dopamine (2329) 2329
tyrosine hydroxylase (2295) 2295
humans (2134) 2134
tyrosine 3-monooxygenase - analysis (2114) 2114
neurons (2094) 2094
dopamine - metabolism (2080) 2080
rats, sprague-dawley (1852) 1852
tyrosine 3-monooxygenase - genetics (1717) 1717
parkinson's disease (1670) 1670
tyrosine (1652) 1652
brain (1457) 1457
neurons - metabolism (1428) 1428
parkinsons-disease (1350) 1350
tyrosine 3-monooxygenase (1228) 1228
disease models, animal (1194) 1194
biochemistry & molecular biology (1166) 1166
mice, inbred c57bl (1068) 1068
neurons - drug effects (1068) 1068
tyrosine-hydroxylase (1028) 1028
neurology (976) 976
time factors (955) 955
hydroxylases (930) 930
analysis (916) 916
rat (891) 891
substantia-nigra (891) 891
rats, wistar (884) 884
substantia nigra (807) 807
expression (803) 803
cells, cultured (796) 796
cell biology (777) 777
neurons - cytology (741) 741
neurons - physiology (713) 713
rodents (711) 711
gene expression (707) 707
substantia nigra - metabolism (706) 706
neurons - enzymology (704) 704
pharmacology & pharmacy (685) 685
corpus striatum - metabolism (681) 681
analysis of variance (679) 679
brain - metabolism (671) 671
hydroxylase (662) 662
phenols (657) 657
article (656) 656
rna, messenger - metabolism (643) 643
rats, inbred strains (641) 641
dopamine - physiology (640) 640
messenger-rna (621) 621
nervous system (618) 618
corpus striatum - drug effects (607) 607
substantia nigra - drug effects (602) 602
phosphorylation (600) 600
dose-response relationship, drug (573) 573
physiological aspects (548) 548
striatum (540) 540
14-3-3 proteins (512) 512
cell count (508) 508
proteins (508) 508
oxidative stress (505) 505
motor activity - drug effects (497) 497
catecholamines (495) 495
gene-expression (487) 487
rat-brain (487) 487
animals, newborn (479) 479
substantia nigra - pathology (472) 472
pregnancy (467) 467
dopaminergic-neurons (463) 463
tyrosine 3-monooxygenase - biosynthesis (462) 462
norepinephrine - metabolism (459) 459
central-nervous-system (449) 449
clinical neurology (440) 440
catecholamines - metabolism (438) 438
basal ganglia (436) 436
cells (431) 431
mptp (425) 425
in-vivo (423) 423
molecular sequence data (423) 423
middle aged (417) 417
mesencephalon - cytology (416) 416
research (415) 415
adult (414) 414
endocrinology & metabolism (410) 410
multidisciplinary sciences (407) 407
neurons - pathology (404) 404
norepinephrine (403) 403
ventral tegmental area (403) 403
neurodegenerative diseases (400) 400
neurodegeneration (394) 394
dopamine receptors (390) 390
6-hydroxydopamine (389) 389
in-vitro (374) 374
mice, transgenic (374) 374
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10579) 10579
Japanese (27) 27
French (21) 21
Russian (20) 20
Chinese (17) 17
German (7) 7
Spanish (5) 5
Hungarian (2) 2
Polish (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, pp. e0158847 - e0158847
Journal Article
Brain, ISSN 0006-8950, 11/2007, Volume 130, Issue 11, pp. 2898 - 2914
The cardinal symptoms in Parkinson's disease (PD), akinesia, rigidity and tremor, are only observed when the striatal level of dopamine is decreased by 60-80%.... 
Immunohistology | Parkinson's disease | MPTP | Behaviour | Compensation | Monkey | NEURONAL-ACTIVITY | monkey | BASAL GANGLIA | DOPAMINERGIC-NEURONS | SELF-ORGANIZED ACTIONS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED PARKINSONISM | SUBSTANTIA-NIGRA | NEUROSCIENCES | CLINICAL NEUROLOGY | immunohistology | SUBTHALAMIC NUCLEUS | behaviour | compensation | RATING-SCALE | IDIOPATHIC PARKINSONS-DISEASE | COGNITIVE DEFICITS | Globus Pallidus - chemistry | Immunohistochemistry | Dopamine Plasma Membrane Transport Proteins - metabolism | Serotonin - analysis | Tyrosine 3-Monooxygenase - metabolism | MPTP Poisoning - psychology | Mesencephalon - metabolism | Biomarkers - analysis | Cercopithecus aethiops | Male | Mesencephalon - chemistry | Tyrosine 3-Monooxygenase - analysis | Dopamine Agents - poisoning | Behavior, Animal | Parkinson Disease, Secondary - pathology | Globus Pallidus - metabolism | Animals | Serotonin - metabolism | Parkinson Disease, Secondary - psychology | Dopamine Plasma Membrane Transport Proteins - analysis | Parkinson Disease, Secondary - chemically induced | Globus Pallidus - pathology | Disease Models, Animal | Mesencephalon - pathology | Index Medicus | Abridged Index Medicus | MPTP Poisoning | Parkinson Disease, Secondary | Globus Pallidus | Mesencephalon | Serotonin | Biological Markers | Tyrosine 3-Monooxygenase | Dopamine Plasma Membrane Transport Proteins | Dopamine Agents
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 07/2018, Volume 65, Issue 7, pp. e27052 - n/a
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 01/2006, Volume 26, Issue 2, pp. 467 - 478
In Alzheimer's disease ( AD), there is a significant loss of locus ceruleus (LC) noradrenergic neurons. However, functional and anatomical evidence indicates... 
Norepinephrine | In situ hybridization | Alzheimer's disease | Hippocampus | Adrenoreceptors | Locus ceruleus | norepinephrine | SENILE DEMENTIA | HUMAN ALPHA-2-ADRENERGIC RECEPTOR | locus ceruleus | hippocampus | adrenoreceptors | TYROSINE-HYDROXYLASE | CEREBROSPINAL-FLUID | NEURONAL LOSS | NEUROSCIENCES | DUAL-PROBE MICRODIALYSIS | ADRENERGIC PROJECTION | TRANSPORTER MESSENGER-RNA | HUMAN-BRAIN | RAT-BRAIN | in situ hybridization | Receptors, Adrenergic, alpha-1 - metabolism | Receptors, Adrenergic, alpha-2 - genetics | Locus Coeruleus - chemistry | Hippocampus - chemistry | Norepinephrine - physiology | Humans | Middle Aged | Nerve Tissue Proteins - analysis | Receptors, Adrenergic, alpha-2 - metabolism | Prazosin - metabolism | RNA, Messenger - analysis | Male | Dendrites - ultrastructure | Alzheimer Disease - pathology | RNA, Messenger - biosynthesis | Receptors, Adrenergic, alpha-1 - analysis | In Situ Hybridization | Fluoxetine - analogs & derivatives | Aged, 80 and over | Adult | Female | Idazoxan - analogs & derivatives | Locus Coeruleus - pathology | Lewy Body Disease - pathology | Hippocampus - pathology | Tyrosine 3-Monooxygenase - analysis | Receptors, Adrenergic, alpha-2 - analysis | Nerve Tissue Proteins - genetics | Adrenergic alpha-Antagonists - metabolism | Lewy Body Disease - metabolism | Nerve Tissue Proteins - metabolism | Tyrosine 3-Monooxygenase - biosynthesis | Tyrosine 3-Monooxygenase - genetics | Idazoxan - metabolism | Norepinephrine - chemistry | Receptors, Adrenergic, alpha-1 - genetics | Alzheimer Disease - metabolism | Fluoxetine - metabolism | Norepinephrine Plasma Membrane Transport Proteins - analysis | Aged | Tetralones - metabolism | Norepinephrine Plasma Membrane Transport Proteins - metabolism | Index Medicus | Neurobiology of Disease
Journal Article
Neurology, ISSN 0028-3878, 09/2000, Volume 55, Issue 6, pp. 811 - 815
To improve diagnostic criteria for sporadic Creutzfeldt-Jakob disease (CJD). Pooled data on initial and final diagnostic classification of suspected CJD... 
Creutzfeldt-Jakob Syndrome - physiopathology | Prospective Studies | Creutzfeldt-Jakob Syndrome - cerebrospinal fluid | Brain - physiopathology | Humans | Sensitivity and Specificity | 14-3-3 Proteins | Electroencephalography | Tyrosine 3-Monooxygenase - analysis | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Korean Medical Science, ISSN 1011-8934, 02/2016, Volume 31, Issue 2, pp. 171 - 177
We investigated the potential of human dental pulp stem cells (hDPSCs) to differentiate into dopaminergic neurons in vitro as an autologous stem cell source... 
Parkinson disease | Dopaminergic Neural Cells | Tyrosine hydroxylase | Dopaminergic Differentiation | Human Dental Pulp Stem Cells | Autologous Stem Cell Therapy | Human dental pulp stem cells | Dopaminergic neural cells | Autologous stem cell therapy | Dopaminergic differentiation | SURVIVAL | EXFOLIATED DECIDUOUS TEETH | LEUKEMIA INHIBITORY FACTOR | Tyrosine Hydroxylase | Parkinson Disease | MEDICINE, GENERAL & INTERNAL | THERAPY | MODELS | ES CELLS | BRAIN | PARKINSONS-DISEASE | Glial Fibrillary Acidic Protein - genetics | Tyrosine 3-Monooxygenase - metabolism | Dopaminergic Neurons - pathology | Humans | Tubulin - genetics | Stem Cells - cytology | Stage-Specific Embryonic Antigens - genetics | Glial Fibrillary Acidic Protein - metabolism | Stem Cells - metabolism | Dopaminergic Neurons - cytology | Myelin Basic Protein - genetics | Stage-Specific Embryonic Antigens - metabolism | Tubulin - metabolism | Dopaminergic Neurons - metabolism | Culture Media - chemistry | Real-Time Polymerase Chain Reaction | Enzyme-Linked Immunosorbent Assay | Myelin Basic Protein - metabolism | Cells, Cultured | Dental Pulp - cytology | Tyrosine 3-Monooxygenase - analysis | Mice, Inbred ICR | Tyrosine 3-Monooxygenase - genetics | Animals | Cell Differentiation - drug effects | Culture Media - pharmacology | Brain - pathology | Stem Cells - pathology | Mice | Index Medicus | Original
Journal Article